Patent Assignment
Reel/Frame 057991/0977
Assignment of Assignor's Interest
Recorded: 2021-11-02
Pages: 14
Assignors
CARTA, LUCA
Executed: 2019-02-06
WILLIAMS, THERESA M.
Executed: 2018-12-17
HUTCHESON, REBECCA
Executed: 2018-12-06
SCHMERTZLER, MICHAEL
Executed: 2018-12-11
HADARI, YARON R.
Executed: 2019-02-05
REYNOLDS, CHARLES H.
Executed: 2018-12-07
Assignee
SHY THERAPEUTICS, INC.
34 BATES ROAD, HARRISON, NEW YORK, 10528
Covered Properties
(6)
Compounds That Interact with the Ras Superfamily for the Treatment of Cancers, Inflammatory Diseases, Rasopathies, and Fibrotic Disease
Compounds That Interact with the Ras Superfamily for the Treatment of Cancers, Inflammatory Diseases, Rasopathies, and Fibrotic Disease
Compounds That Interact with the Ras Superfamily for the Treatment of Cancers, Inflammatory Diseases, Rasopathies, and Fibrotic Disease
Compounds That Interact with the Ras Superfamily for the Treatment of Cancers, Inflammatory Diseases, Rasopathies, and Fibrotic Disease
Patent:
11,026,930 →
Application:
16/847,467 →
Compounds That Interact with the Ras Superfamily for the Treatment of Cancers, Inflammatory Diseases, Rasopathies, and Fibrotic Disease
Application:
17/143,084 →
Publication:
US 2022/0347162
Compounds That Interact with the Ras Superfamily for the Treatment of Cancers, Inflammatory Diseases, Rasopathies, and Fibrotic Disease
Patent:
11,213,515 →
Application:
17/143,077 →